• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Impact of treatment and clinical factors on worsening of functional scales after prostate cancer RT

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Cicchetti, A.
    Joseph, N.
    Choudhury, Ananya
    Avuzzi, B.
    Valdagni, R.
    Rancati, T.
    Seibold, P.
    Chang-Claude, J.
    Azria, D.
    Vega, A.
    Webb, A.
    Talbot, C.
    Elliott, Rebecca M
    Sperk, E.
    De Ruysscher, D.
    Veldeman, L.
    Lambrecht, M.
    West, Catharine M L
    Show allShow less
    Affiliation
    Fondazione IRCCS Istituto Nazionale dei Tumori, Prostate Cancer Program, Milan, Italy
    Issue Date
    2021
    
    Metadata
    Show full item record
    Abstract
    Purpose or Objective The study aimed to evaluate the deterioration of functional outcomes in localized prostate cancer (PCa) patients (pts) treated with external beam radiotherapy (RT) with a focus on oncological treatment and patient features. Materials and Methods EORTC QLQ-C30 (version 3.0) was administered to pts enrolled in a multicenter prospective observational study. For this analysis, we specifically considered one symptom scale (Fatigue) and three functional scales (Physical, Role, Social) at three time-points: baseline, RT end and 2-year after RT. The average score variation in acute and late phases as stratified by treatment and patient factors was determined. We used radar plots to report results quantitatively, and we computed the hexagonal areas from these plots to obtain a summary variable describing the functional status. Worsening in at least 2 (wrs2) or 3 (wrs3) scales were considered as additional endpoints, with cut-offs for clinically significant deterioration defined as suggested by Cooks et al. (EJC 2012). Results A total of 1143 pts with complete information were available. Among treatment features, we considered: prostatectomy, pelvic irradiation (LN), hormone-therapy and fractionation (2-2.65 Gy/fr vs 2.7-3.4 Gy/fr). We explored age, diabetes and urinary symptoms at baseline as patient characteristics. Figure 1 shows a panel of radar plots with scores for the different scales. Table 1 reports hexagonal areas and the prevalence of wrs2/wrs3 as a function of investigated characteristics and time-points. The Ratio of the hexagonal regions “(at RT end)/(at 2-year)” is reported as an index for the recovery of acute effects. Diabetes slows down the impact of RT on functional and symptom scales with a continuous deterioration at 2- year (Ratio=0.85), which is characterized by the best incidence of wrs2 and 3 post-RT and worst incidences in the late phase. Moderate hypofractionation strongly affects the acute phase (Area, wrs2 and 3 incidences), showing at the same time the best recovery index at 2-year. Age does not affect the acute phase but takes part in the recovery capability. Patients who underwent prostatectomy are no more affected by the treatment, probably, because of the long lapse of time between surgery and RT (average time 2.7 year). Small differences are found between patients irradiated or not to LN. As a potential explanation we could mention the difference in the average dose/fraction for patients with and without LN irradiation, 2.00 Gy/fr vs 2.3 Gy/fr, respectively. Finally, Area of pts with and without urinary dysfunctions are well-differentiated only at 2-year, while it is the opposite with hormone-therapy treatment. Conclusion Results from the EORTC QLQ-C30 highlighted a large variability in the deterioration of functional and symptom scales with time. Moderate hypofractionation impacts the QoL acute perception of prostate cancer patients, while diabetes strongly affects the late phase after a better acute condition than the other analyzed characteristics.
    Citation
    Cicchetti A, Joseph N, Choudhury A, Avuzzi B, Valdagni R, Rancati T, et al. Impact of treatment and clinical factors on worsening of functional scales after prostate cancer RT. Radiotherapy and Oncology. 2021;161:S596-S8.
    Journal
    Radiotherapy and Oncology
    URI
    http://hdl.handle.net/10541/624829
    Type
    Meetings and Proceedings
    Language
    en
    Collections
    All Christie Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.